Himadri Speciality Chemical Acquires 16.24% Stake in US-Based Battery Firm IBC

Himadri Speciality Chemical Ltd (HSCL) has completed its acquisition of a 16.24% stake in International Battery Company, Inc. (IBC), a corporation based in Delaware. The deal is valued at $4.43 million and has been executed entirely in cash, as per the exchange filing.

Share Purchase and Subscription

The transaction included multiple components. Himadri Speciality Chemical purchased 600,000 common shares from an existing shareholder of IBC. Alongside this, the company subscribed to 2,100,000 new common shares issued by IBC. Additionally, Himadri Speciality Chemical subscribed to 379,175 Series A Preferred shares of the company.

Timeline of Events

The company’s board had initially approved the acquisition on May 22, 2025. Following this approval, the required disclosures were made to the stock exchanges on the same date. The company has now confirmed that the purchase consideration has been paid and the transaction is closed.

The latest update was submitted under Regulation 30 of SEBI’s Listing Obligations and Disclosure Requirements Regulations, 2015. The company also cited compliance with the SEBI Master Circular dated November 11, 2024, for corporate announcements.

Read more: India Launches EV Scheme Portal: Import Tax Cuts in Exchange for Local Investment!

Himadri Speciality Chemical Share Price Performance

As of 10:09 AM on June 25, 2025, Himadri Speciality Chemical share price was trading at ₹452.65, a 2.86% increase, with a 21.97% decline over the past 6 months and a 10.21% increase over the past year.

Conclusion

With the payment and subscription now completed, Himadri Speciality Chemical holds a 16.24% equity stake in IBC on a fully diluted basis. No further operational or strategic details have been mentioned in this filing. The company has requested the exchanges to take the update on record.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.